ClinicalTrials.Veeva

Menu

Relation Between Body Mass Index and Endometrial Thickness

A

Aljazeera Hospital

Status

Unknown

Conditions

Postmenopausal Bleeding

Treatments

Diagnostic Test: transvaginal ultrasound

Study type

Observational

Funder types

Other

Identifiers

NCT03841916
Body mass index

Details and patient eligibility

About

Postmenopausal Bleeding (PMB) is defined as recurrent attacks of bleeding occurring in women after menopause one year at least after stoppage of cycles [

Full description

Premalignant lesions and malignant lesions most commonly complex hyperplasia with atypia and carcinoma of the endometrium are present in 1/3 of patients evaluated for postmenopausal bleed-ing, and so investigations for cases of postmeno-pausal bleeding are mandatory

Enrollment

200 estimated patients

Sex

Female

Ages

45 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • menopausal women (defined as minimum of 1 year of amenorrhea after the age of 45 years if only the amenorrhea is not related to pregnancy, medication or disease),

Exclusion criteria

  • Women with chronic diseases as diabetes mellitus, hypertension or hematological disorders, those received hormone replacement therapy, Tamoxifen or anticoagulant therapy and women with adnexal massed detected by TVUS or apparent causes of bleeding from cervix or vagina e.g. ulcer were excluded.

Trial contacts and locations

1

Loading...

Central trial contact

Mahmoud Alalfy, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems